"Even as someone who had long advocated for remote monitoring using eSource, I found myself astounded at the success our team achieved" using it during the pandemic.
This paper tracks the journey of Clinical Research Management graduate students who were faced with having to readjust their capstone project activities while in lockdown at the height of the COVID-19 pandemic, yet still meet the project deliverables.
The fact that decentralized clinical trials are no fad is good news for patients with obvious advantages, but the trend may seem daunting for small-to-midsized biotechnology and biopharmaceutical companies.
The digitalization of trials and centralized statistical monitoring has generated the need for a new breed of data analysts—people with a broad range of skills and with a promise of significant job satisfaction.
Though some challenges will be naturally mitigated as the decentralized clinical trial (DCT) process matures, others have demonstrated why DCTs will never be a one-size-fits-all solution for patients and clinical trial teams.